×
Home
Archive Submission Guidelines
News Contact
Original article
Crossmark

Prognostic value of the right ventricle diameter, pulmonary arterial pressure and biomarkers in patients with acute heart failure

By
Dejan Petrović ,
Dejan Petrović
Marina Deljanin-Ilić Orcid logo ,
Marina Deljanin-Ilić
Sanja Stojanović Orcid logo ,
Sanja Stojanović
Dejan Simonović ,
Dejan Simonović
Dijana Stojanović ,
Dijana Stojanović
Valentina Mitić ,
Valentina Mitić
Milovan Stojanović
Milovan Stojanović

Abstract

The aim of the paper was to examine the echocardiographic parameters of the right ventricle (RV), its diameter and pulmonary arterial pressure (PAP); to determine their relationship to B-type natriuretic peptide (BNP), troponin and (TnI) and high-sensititity C-raective protein (hsCRP), and to evaluate their prognostic significance to one-year mortality in patients with acute heart failure (AHF). The study included a total of 225 patients (pts) (70.29 ± 9.74 years) who were admitted to Intensive care unit due to the signs and symptoms of AHF. The values of standard biochemical parameters, BNP, TnI and hsCRP were determined during the first 24 hours after admission. All patients underwent echocardiographic examination. During a one-year follow-up, 78 (34.70%) patients died. As compared with the group of survivors (n = 147), the group of non-survivors had higher values of BNP (853.10 ± 384.92 vs. 1399.68 ± 464.44 pg/mL, p < 0.001), TnI (0.59 ± 2.04 vs. 2.00 ± 8.29 ng/ml, p < 0.05), right ventricular diameter and PAP (p < 0.001). BNP was positively correlated with TnI (r = 0.311), PAP (r = 0.255) and right ventricular diameter (r = 0.304, p < 0.001 for all correlations). The cut-off value of BNP ≥ 1062.04 pg/ml, PAP ≥ 44.5 mmHg and TnI ≥ 0.04 ng/ml were associated with a higher risk of mortality. Our results have shown that BNP, PAP and TnI are strong and independent predictors of one-year mortality in hospitalized patients with acute heart failure.

References

1.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure. 2016;18(8):891–975.
2.
Petrovic D, Deljanin-Ilic M, Stojanovic S. Prognostic value of biomarkers and co-morbidities in patients with acute heart failure: One-year follow-up study. Srpski arhiv za celokupno lekarstvo. 2017;145(3–4):118–23.
3.
Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, et al. EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot). European Journal of Heart Failure. 2013;15(7):808–17.
4.
Hobbs F. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). European Heart Journal. 2000;21(22):1877–87.
5.
Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea. New England Journal of Medicine. 2004;350(7):647–54.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.